JuLib | Articles & more

1

Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival

Wintz, Katharina
2023

Biomedicines, 11 (2023) 4, S. 995 -

OpenAccess

2

Journal Article

Evaluation of the 18F-Labeled Analog of the Therapeutic All-d-enantiomeric Peptide RD2 for Amyloid β Imaging

Willuweit, Antje
2023

European journal of pharmaceutical sciences, 184 (2023) S. 106421

OpenAccess

3

Journal Article

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1G93A Transgenic Mice

Post, Julia
2021

International journal of molecular sciences, 22 (2021) 13, S. 7066 -

OpenAccess

4

Journal Article

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Camargo, Luana
2021

International journal of molecular sciences, 22 (2021) 13, S. 7062 -

OpenAccess

5

Journal Article

A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model

Post, Julia
2021

Molecules, 26 (2021) 6, S. 1590 -

Get full text OpenAccess

6

Journal Article

Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography

Willuweit, Antje
2021

Frontiers in neuroscience, 15 (2021) S. 699926

OpenAccess

7

Journal Article

Camargo, Luana Cristina
2021

Biomedicines, 9 (2021) 9, S. 1160 -

OpenAccess

8

Journal Article

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Schemmert, Sarah
2019

Molecular neurobiology, 56 (2019) 3, S. 2211-2223

Get full text Get full text OpenAccess OpenAccess

9

Journal Article

Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2

Schemmert, Sarah
2019

Neurobiology of disease, 124 (2019) S. 36-45

Get full text OpenAccess Get full text OpenAccess

10

Journal Article

Comprehensive characterization of the pyroglutamate Aβ induced motor neurodegenerative phenotype of TBA2.1 mice

Dunkelmann, Tina
2018

Journal of Alzheimer's disease, 63 (2018) 1, S. 115-130

Get full text OpenAccess Get full text OpenAccess

11

Journal Article

In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease

Schartmann, Elena
2018

Journal of Alzheimer's disease, 64 (2018) 3, S. 859 - 873

Get full text OpenAccess OpenAccess

12

Journal Article

Aβ oligomer eliminating compounds interfere successfully with pEAβ (3–42) induced motor neurodegenerative phenotype in transgenic mice

Dunkelmann, Tina
2018

Neuropeptides, 67 (2018) S. 27-35

13

Journal Article

Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all- d -enantiomeric peptides developed for the treatment of Alzheimer's disease

Schartmann, Elena
2018

European journal of pharmaceutical sciences, 114 (2018) S. 93 - 102

14

Journal Article

Pharmacokinetic Properties of a Novel d-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers

Leithold, Leonie H. E.
2016

Pharmaceutical research, 33 (2016) 2, S. 328-36

15

Journal Article

Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d-enantiomeric peptide

Jiang, Nan
2016

Biochimica et biophysica acta / Biomembranes, 1858 (2016) 11, S. 2717 - 2724

16

Journal Article

Pharmacokinetic properties of tandem d-peptides designed for treatment of Alzheimer's disease

Leithold, Leonie H. E.
2016

European journal of pharmaceutical sciences, 89 (2016) S. 31 - 38

17

Journal Article

Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease

Jiang, Nan
2015

PLoS one, 10 (2015) 6, S. e0128553 -

OpenAccess OpenAccess

18

Journal Article

QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers

Brener, Oleksandr
2015

Scientific reports, 5 (2015) S. 13222

Get full text OpenAccess OpenAccess

Narrow Search Results